Epigenetic modulator LSD1, a theragnostic target for potentially malignant oral disorders and malignant lesions

Epigenomics, Ahead of Print.

Source: Future Medicine: Epigenomics - November 9, 2022 Category: Genetics & Stem Cells Authors: Vijayashree Priyadharsini Jayaseelan Paramasivam Arumugam Source Type: research